ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Credit Suisse Asset Management Fund Inc

Credit Suisse Asset Management Fund Inc (CIK)

2.95
-0.022
(-0.74%)
Closed December 17 4:00PM
2.94
0.00
(0.00%)
After Hours: 5:41PM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
2.95
Bid
-
Ask
-
Volume
620,124
2.93 Day's Range 2.96
2.82 52 Week Range 3.19
Market Cap
Previous Close
2.972
Open
2.96
Last Trade
500
@
2.95
Last Trade Time
Financial Volume
$ 1,824,571
VWAP
2.9423
Average Volume (3m)
574,679
Shares Outstanding
53,090,307
Dividend Yield
9.15%
PE Ratio
6.00
Earnings Per Share (EPS)
0.49
Revenue
17.74M
Net Profit
26M

About Credit Suisse Asset Management Fund Inc

Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company.

Sector
Unit Inv Tr, Closed-end Mgmt
Industry
Unit Inv Tr, Closed-end Mgmt
Headquarters
New York, New York, USA
Founded
-
Credit Suisse Asset Management Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the American Stock Exchange with ticker CIK. The last closing price for Credit Suisse Asset Mana... was $2.97. Over the last year, Credit Suisse Asset Mana... shares have traded in a share price range of $ 2.82 to $ 3.19.

Credit Suisse Asset Mana... currently has 53,090,307 shares outstanding. The market capitalization of Credit Suisse Asset Mana... is $157.78 million. Credit Suisse Asset Mana... has a price to earnings ratio (PE ratio) of 6.00.

CIK Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.03-1.00671140942.982.992.945930082.97330525CS
40.010.3401360544222.943.022.946224572.97811387CS
12-0.14-4.530744336573.093.1052.935746793.00694706CS
26-0.06-1.993355481733.013.1252.894317363.01780561CS
52-0.09-2.960526315793.043.192.822967053.00413202CS
156-0.47-13.74269005853.423.52.392399882.88152436CS
260-0.29-8.950617283953.243.641.974892123.11948636CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SYNXSilynxcom Ltd
$ 3.97
(37.46%)
484.7k
OSTXOS Therapies Incorporated
$ 4.71
(35.34%)
670.64k
YCBDcbdMD Inc
$ 0.438999
(29.12%)
1.79M
CVMCel Sci Corporation New
$ 0.7636
(17.48%)
841.17k
MRTMarti Technologies Inc
$ 3.20
(15.11%)
80.42k
UAVSAgEagle Aerial Systems Inc
$ 5.545
(-18.70%)
1.31M
TMFMMotley Fool Midcap Growth ETF
$ 26.84
(-14.30%)
10.02k
UMACUnusual Machines Inc
$ 11.307
(-13.62%)
3.95M
MYNDMynd ai Inc
$ 1.871
(-13.38%)
95.07k
MMAMixed Martial Arts Group Limited
$ 1.25
(-12.59%)
20.48k
TSLZT Rex 2X Inverse Tesla Daily Target ETF
$ 1.9248
(-7.24%)
95.77M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 3.75
(2.60%)
70.62M
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 31.13
(-4.24%)
64.5M
SPYSPDR S&P 500
$ 604.29
(-0.41%)
54.97M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
$ 5.84
(1.39%)
52.47M

Discussion

View Full Feed
JMoneyHoops JMoneyHoops 2 minutes ago
Verified profile! https://x.com/jmoney_hoops/status/1869205515588501520?s=46&t=EuLw-SVIgNfV5yGP5vc4tQ
EATR
dstock07734 dstock07734 2 minutes ago
Yes
NWBO
KILLAZILLA KILLAZILLA 3 minutes ago
DILUTION IS THE MAIN EYESORE....

WITHOUT SUBSTANTIAL REVENUE IT'S A POS DILUTION SCAM......
TLRY
gitreal gitreal 3 minutes ago
...where would our country be without folks daring to dream?

Pretty sad that you can't tell the difference between a grifting penny stock CEO and a legit startup entrepreneur. Or, even worse, you do know the difference and you are pretending, just to help promote the scam. I think i
NBRI
flipper44 flipper44 4 minutes ago
Those people know we can still see them, right?
NWBO
awesomed007 awesomed007 4 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
awesomed007 awesomed007 4 minutes ago
If it was selling on heavy volume, that would be a concern but very light volume during end of year portfolio rebalancing, tax harvesting happening, nah, just a few fools selling.
RDAR
Eatatjoes Eatatjoes 4 minutes ago
Paul Malec of Deer Park, NY
QOIL
fuagf fuagf 4 minutes ago
Yeps, yeps and yeps. Good ones.
NoMoDo NoMoDo 4 minutes ago
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175527881 Meeting announced for TODAY

Better yet. Read this closely:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175530469
Ybyra agreed to purchase a company in France. Giving Dividends.
HMBL
manibiotech manibiotech 5 minutes ago
Well if you read the link you posted yourself , they are tracking in almost every other country on the planet . Please see the table . They are giving projected global scope of what is going on
I have no problem with you posting that link every hour of that pleases you 
NWBO
1vman 1vman 5 minutes ago
*****🚽UBQU🚽 Kevin Lamb is the typical OTC CEO , pocketing money while share holders lose amost all their investment

So much for forbes and da T0P 10 Health innovators wow!

🤔HUZZAH ENOUGH SAID !!!🤔
UBQU
janice shell janice shell 6 minutes ago
First of all, Syria is not a big oil producer. So it's a stupid idea. Trump has put it forward because he thinks everything should be his.

And because he's a moron.

https://investorshub.advfn.com/uimage/uploads/2024/12/17/oage%5BJPEG_image.jpeg

I must so
HappyAlways HappyAlways 7 minutes ago
I am, as a Fannie shareholder, against any government action to dilute Fannie shareholders' interest. (1) The PSPA loan is no longer valid, given the NWS payments are way over the original 10% interest payments by $310B. (2) Any attempt to exercise the free warrant will be met with lawsuits, given t
FNMA
TheDane TheDane 7 minutes ago
Not only did it hold but it’s on the way back up.
SMCI
OnTrack444 OnTrack444 7 minutes ago
Might see a dime after the RS!  

If you think a 30B OS OTC stock is going to run from .0011 to .10 you're smoking something pretty whacky!!  Find a low OS stock with catalysts in place and it's entirely possible but not this one my friend!!!  GLTY
HMBL
manibiotech manibiotech 8 minutes ago
Interesting for sure but not conclusive which he repeat every day 

But there are other things mentioned in that paragraph besides "Neuroscience" ( not Neuro-oncology). And there are other categories of vaccines in development even in neuroscience 


NWBO
FACT-MASTER FACT-MASTER 9 minutes ago
Pivotal Study Design.

Through a meeting with the FDA, the Company obtained feedback on the potential registrational pathway following the Phase 1 ALLOHA trial. Based on this feedback, the Company believes that for a registrational trial: (1) the following proposed patient population i
CDMO
arizona1 arizona1 10 minutes ago
Never trumpers are hilarious and brilliant too.
jimr1717 jimr1717 11 minutes ago
“ which now includes 17 issued U.S. patents and 84 pending”

It has taken them from $90,000 to $2 bucks in share price to get 17 of 101 patents.

There will be people that might need a million dollar share price to brake even by then.

This Fake it sham is
SINT
NoMoDo NoMoDo 12 minutes ago
If we don't see a dime, I will be shocked.
HMBL
Slyhunter Slyhunter 12 minutes ago
I did Uber, when it was worth doing. Made, sometimes $300 a day at the b3e3ginning when they first started in my county, It was disastrous to not get out of the car and inspect the backseat to insure it was clean between fares, especially when driving dr8u8nks home at night. I don't see how Tesla is
TSLA
nfrequent nfrequent 12 minutes ago
Get ready. Phase One complete!!!
https://archive.fast-edgar.com/20241217/AP2Z522CZZ2R52V222JG2WY2CDQEZZ226L62/
RNVA
XMaster2023 XMaster2023 12 minutes ago
Well now kinda sensitive. We can only talk about others tracking the approval one time because it doesn’t meet your short agenda? Funny how an American Society are tracking approval in the UK. They understand the approval will have a big impact on the gene therapy world. Your tacid comments will
NWBO